| Identification | Back Directory | [Name]
BMS 566394 | [CAS]
503166-51-6 | [Synonyms]
BMS 566394
(3R,4R)-N-hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamide
(3R,4R)-N-hydroxy-4-(4-((2-(trifluoroMethyl)-1H-benzo[d]iMidazol-1-yl)Methyl)benzaMido)tetrahydro-2H-pyran-3-carboxaMide
(3R,4R)-Tetrahydro-N-hydroxy-4-[[4-[[2-(trifluoromethyl)-1H-benzimidazol-1-yl]methyl]benzoyl]amino]-2H-pyran-3-carboxamide
2H-Pyran-3-carboxamide, tetrahydro-N-hydroxy-4-[[4-[[2-(trifluoromethyl)-1H-benzimidazol-1-yl]methyl]benzoyl]amino]-, (3R,4R)- | [Molecular Formula]
C22H21F3N4O4 | [MOL File]
503166-51-6.mol | [Molecular Weight]
462.42 |
| Hazard Information | Back Directory | [Uses]
(3R,4R)-Tetrahydro-N-hydroxy-4-[[4-[[2-(trifluoromethyl)-1H-benzimidazol-1-yl]methyl]benzoyl]amino]-2H-pyran-3-carboxamide, in conjunction with unique constrained β-amino hydroxamic acid scaffolds for the discovery of potent selective inhibitors of TNF-α Converting Enzyme (TACE). |
|
| Company Name: |
Tetranov Biopharm
|
| Tel: |
13526569071 |
| Website: |
http://www.leadmedpharm.com/index.html |
|